antibody assay Method directed against the factor viii

The present invention relates to a method for identifying and monitoring a therapeutic treatment aimed at eliminating the immune response directed against human factor VIII in a haemophilia patient, comprising, respectively, the specific assaying, in a sample from said patient, of the inhibitory antibodies directed against human factor VIII, and the specific assaying, in a sample from said patient, of the corresponding anti-idiotypic antibody.